Letter to the Editor

On “Management of Cocaine-Induced Myocardial Infarction: 4-Year Experience at an Urban Medical Center”

Authors: John R. Richards, MD

Abstract

To the Editor: I enjoyed reading the outstanding study on the management of cocaine-induced myocardial infarction by Chibungu and colleagues.1 I would like to comment specifically on the differences observed between cocaine-positive versus cocaine-negative patients receiving β- blockers.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Chibungu A, Gundareddy V, Wright SM, et al. Management of cocaine-induced myocardial infarction: 4-year experience at an urban medical center. South Med J 2016;109:185-190.
 
2. McCord J, Jneid H, Hollander JE, et al. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation 2008;117:1897-1907.
 
3. Dattilo PB, Hailpern SM, Fearon K, et al. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use. Ann Emerg Med 2008;51:117-125.
 
4. Mohamad T, Kondur A, Vaitkevicius P, et al. Cocaine-induced chest pain and beta-blockade: an inner city experience. Am J Ther 2008;15:531-535.
 
5. Rangel C, Shu RG, Lazar LD, et al. Beta-blockers for chest pain associated with recent cocaine use. Arch Intern Med 2010;170:874-879.
 
6. Ibrahim M, Maselli DJ, Hasan R, et al. Safety of β-blockers in the acute management of cocaine-associated chest pain. Am J Emerg Med 2013;31:613-616.
 
7. Fanari Z, Kennedy KK, Lim MJ, et al. Comparison of in-hospital outcomes for beta-blocker use versus non-beta blocker use in patients presenting with cocaine-associated chest pain. Am J Cardiol 2014;113:1802-1806.
 
8. Gupta N, Washam JB, Mountantonakis SE, et al. Characteristics, management, and outcomes of cocaine-positive patients with acute coronary syndrome (from the National Cardiovascular Data Registry). Am J Cardiol 2014;113:749-756.
 
9. Richards JR, Garber D, Laurin EG, et al. Treatment of cocaine cardiovascular toxicity: a systematic review. Clin Toxicol (Phila) 2016;54:345-364.